3/19
08:15 am
adtx
Aditxt Subsidiary Ignite Proteomics Appoints Public Company Veteran Jeff Busch as Chief Executive Officer
High
Report
Aditxt Subsidiary Ignite Proteomics Appoints Public Company Veteran Jeff Busch as Chief Executive Officer
3/13
02:27 pm
adtx
Aditxt acquires Ignite Proteomics in $36M preferred stock deal; shares down [Seeking Alpha]
Low
Report
Aditxt acquires Ignite Proteomics in $36M preferred stock deal; shares down [Seeking Alpha]
3/13
08:34 am
adtx
Aditxt Acquires Ignite Proteomics to Address a Critical Challenge in Cancer Care: Optimizing Therapy Selection [Yahoo! Finance]
Medium
Report
Aditxt Acquires Ignite Proteomics to Address a Critical Challenge in Cancer Care: Optimizing Therapy Selection [Yahoo! Finance]
3/13
08:15 am
adtx
Aditxt Acquires Ignite Proteomics to Address a Critical Challenge in Cancer Care: Optimizing Therapy Selection
High
Report
Aditxt Acquires Ignite Proteomics to Address a Critical Challenge in Cancer Care: Optimizing Therapy Selection
3/5
09:09 am
adtx
Aditxt announces 1-for-8 reverse stock split [Seeking Alpha]
High
Report
Aditxt announces 1-for-8 reverse stock split [Seeking Alpha]
3/5
08:30 am
adtx
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-8 Reverse Stock Split Effective at the Open of Trading on March 9, 2026
Medium
Report
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-8 Reverse Stock Split Effective at the Open of Trading on March 9, 2026